Russell Griffin
Medical · Atlanta, GANPI 1790088383
Payments from drug & device makers
Across 331 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$1K
- Viiv Healthcare Company$1K
- Endo Pharmaceuticals Inc.$418
- Novo Nordisk$355
- Merck$326
- Otsuka America Pharmaceutical, Inc.$307
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,34698%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 45 | $1,252 |
| Viiv Healthcare Company | 61 | $1,076 |
| Endo Pharmaceuticals Inc. | 20 | $418 |
| Novo Nordisk | 24 | $355 |
| Merck | 16 | $326 |
| Otsuka America Pharmaceutical, Inc. | 14 | $307 |
| Johnson & Johnson | 15 | $297 |
| Lilly USA, LLC | 17 | $271 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $243 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $216 |
| Napo Pharmaceuticals Inc | 6 | $212 |
| AbbVie | 18 | $205 |
| Theratechnologies Inc. | 9 | $149 |
| Eisai Inc. | 10 | $148 |
| Paratek Pharmaceuticals, Inc. | 6 | $130 |
| Janssen Products, LP | 1 | $100 |
| Idorsia Pharmaceuticals US Inc | 5 | $98 |
| Lundbeck LLC | 4 | $93 |
| Antares Pharma, Inc. | 5 | $75 |
| Sanofi-aventis U.S. LLC | 5 | $73 |
| Abbott | 4 | $67 |
| Clarus Therapeutics Inc. | 3 | $42 |
| Vyera Pharmaceuticals, LLC | 2 | $40 |
| Acerus Pharmaceuticals Corporation | 3 | $39 |
| Amgen | 1 | $31 |
| Nabriva Therapeutics, PLC | 2 | $29 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Aytu Biopharma, Inc. | 1 | $20 |
| EMD Serono, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Merz North America, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,446 in reported general payments places this provider in the 85th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 17 | $306 |
| Atorvastatin Calcium | 17 | $136 |
| Levothyroxine Sodium | 12 | $106 |
Paid to pharmacies, not to this prescriber.
Other medical in Atlanta
- Kimberly OrleckAtlanta$727K
- Danna Dennis-CalderAtlanta$87K
- Ferrina ShethAtlanta$49K
- Adriana RuizAtlanta$39K
- Punam PunjaAtlanta$31K
- Adrienne AndersonAtlanta$25K
- Jeremiah RobinsonAtlanta$23K
- Steven SchmittAtlanta$15K
- Taylor WeintraubAtlanta$15K
- Margaret SellersAtlanta$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.